Bibliographic Info
GuidelineUpdated recommendations on treatment of adolescents and children with chronic HCV infection: policy brief.
Year of Publication2022
Issuing InstitutionWorld Health Organization
Recommendation
Status
Maintained
Recommended in favor
Strong
Certainty of evidence
Moderate
We recommend treatment using pangenotypic direct-acting antiviral (DAA) regimens for all adults with chronic hepatitis C infection, regardless of stage of disease
Also Featured In
This recommendation also appears in the following guidelines:
Guideline
Updated recommendations on treatment of adolescents and children with chronic HCV infection, and HCV simplified service delivery and diagnostics.
Year2022
InstitutionWorld Health Organization